Good Products Expands to New Premises
Good Products, a provider of Enterprise Content Management (ECM) solutions and Clinical Technology Consulting for the pharmaceutical, biotechnology and medical device industries, today announced a major expansion to new UK headquarters in Nottingham, UK.
Good Products Expands to New Premises to Accommodate Growing Business
December 23, 2008-Good Products, a leading provider of Enterprise Content Management (ECM) solutions and Clinical Technology Consulting for the pharmaceutical, biotechnology and medical device industries, today announced a major expansion to new UK headquarters in Nottingham, UK. Good Products has seen a significant expansion of its business delivering electronic document management solutions to the pharmaceutical industry in 2008 and the company anticipates further growth in the healthcare industry during 2009, particularly within the small and mid-sized biopharmaceutical sector. As such the company is moving to new larger premises to continue to support its UK and international customers and to accommodate its expanding team.
Good Products' expansion and continued success reflects the continuing need from the pharmaceutical industry for streamlined and compliant regulatory
document management. The relocation reflects the significant growth experienced by Good Products since its inception in 2006. As a result of its
success the company opened a US office in Irvine, California early in 2008 to support its growing North American client base. The company's new premises in the thriving Lenton Lane business district of Nottingham will accommodate Good Product's team of up to 20 staff including new Business Development Manager Michael Brunner. The team has doubled in the last 12 months and the new offices provide the ideal base for significant expansion during 2009.
Keith Williams, CEO, Good Products, comments: "2008 has been a busy year for Good Products, which was founded as a result of identifying a growing need in the pharmaceutical, biotechnology and life sciences sectors to address regulatory and legal pressures through elements of Enterprise Content Management (ECM). During the last two years we have grown from a small company to a global leader in the area of document management and we look forward to continuing our success from these new premises."
During 2008 Good Products launched its Clinical Technology Consulting division, designed to enable biopharmaceutical sponsors and CROs to optimize their use of clinical technology. Since its inception this division has experienced significant growth inception among the sponsor and CRO communities across North America and Europe.
Good Products has advised on a number of regulatory issues including the now mandatory adoption of the eCTD for regulatory submissions. As regulatory requirements become more stringent and new standards come into practice, effective document management is addressed through the extensive g-docs suite of solutions from Good Products.
For more information on Good Products, please visit www.goodproductsEU.com or email info@goodproductsEU.com.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
A Guide to Patient Engagement & Recruitment Solutions
March 18th 2025Clinical trials have become increasingly complex over the past decades, making participant recruitment more challenging than ever. This guide explores common recruitment obstacles and offers strategies to overcome them using a patient engagement and recruitment solution.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Bridging the Gap: How Chiesi Used External Collaboration to Get Closer to Patients
March 18th 2025Chiesi partnered with Citeline to enhance clinical trial awareness and patient engagement through its FREUD initiative by launching a Trial Portfolio Website, activating 150+ sites, and generating 600+ qualified referrals—learn more about how Citeline helped improve study discoverability, streamline recruitment, and strengthen Chiesi’s presence in key therapeutic areas.
Citeline Patient Engagement & Recruitment Solutions
March 18th 2025Watch Citeline’s 15-minute presentation from Clinical Leader’s Patient Engagement & Recruitment Solutions Expo, where VP Matt Holms explores Direct-to-Data (DTD) patient recruitment. This session takes a deep dive into how complex algorithms, tokenized data, and large data assets can optimize enrollment, highlighting the importance of early strategic recruitment planning and breaking down the unique benefits and real-world applications of DTD.
